1Lazarus M, Hajeer AH, Turner D, et al. Genetic variation in the interleukin 10 8ene promoter and systemic lupus erythematosus.J Rheumatol, 1997, 24:2314-2317.
2Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med, 1998.30:469-473.
3Kamizono S, Yamada A, Higuchi T,et al. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease.Pediatr Int, 1999,41:341-345.
4Quasney MW, Brornstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with kawasaki disease. Pediatr Res , 2001,49:686-690.
5Mok CC, Lanchbury JS, Chan DW, et al. Interleukin-10 promoter polymorphism in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum, 1998,41:1090-1095.
6Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor interleukin 2 receptor, and intederon-ganuna in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopsathol, 1990, 56:29-36.
7Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr, 1996,128:146-149.
8Louis E, Franchimont D, Piton A, et al. Tumor necrosis factor(TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 1998,113,401-406.
9Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol, 1997,34:391-399.
10D′ Alfonso S, Rampi M, Bocchio D, et al. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum, 2000,43 : 120-128.
